Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma
Authors
Keywords
-
Journal
JOURNAL OF APPLIED GENETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-02
DOI
10.1007/s13353-023-00785-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma
- (2023) Zhao Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients
- (2023) Tao Han et al. Frontiers in Pharmacology
- Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma
- (2023) Hrituraj Dey et al. Frontiers in Medicine
- N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis
- (2022) Zhipeng Ren et al. Bioengineered
- Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation
- (2022) Hao Zhang et al. Journal of Orthopaedic Surgery and Research
- A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
- (2022) Mingyi Yang et al. Frontiers in Immunology
- The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma
- (2022) Zexin Su et al. Frontiers in Immunology
- Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis
- (2022) Yigang Lv et al. Frontiers in Immunology
- A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
- (2022) Runsang Pan et al. Frontiers in Immunology
- The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma
- (2022) Lin Hu et al. Frontiers in Cell and Developmental Biology
- Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma
- (2022) Fangxing Xu et al. Frontiers in Immunology
- The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma
- (2021) Lijiang He et al. BMC CANCER
- Integrative analysis of immune‐related multi‐omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma
- (2021) Deyao Shi et al. Molecular Oncology
- Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients
- (2021) Bénédicte Brulin et al. Cancers
- Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression
- (2020) Konghe Hu et al. ONCOLOGY REPORTS
- SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis
- (2020) Zhiyun Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
- (2020) Xia Zhu et al. Cancer Management and Research
- Replication stress and FOXM1 drive radiation induced genomic instability and cell transformation
- (2020) Zhentian Li et al. PLoS One
- LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1
- (2019) Bin Shen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
- (2019) Liang Wang et al. OncoTargets and Therapy
- Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma
- (2019) Yongjie Sun et al. Cancer Management and Research
- SIAH1/ZEB1/Il-6 Axis is Involved in Doxorubicin (Dox) Resistance of Osteosarcoma Cells
- (2018) Xiuxin Han et al. BIOLOGICAL CHEMISTRY
- Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma
- (2018) Yang Li et al. CANCER SCIENCE
- Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134
- (2018) Yonggang Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1
- (2018) Wei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
- (2018) Huensuk Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Methylation Mediated Down-Regulation of miR-370 Regulates Cell Growth through Activation of the Wnt/β-Catenin Signaling Pathway in Human Osteosarcoma Cells
- (2017) Wentao Zhang et al. International Journal of Biological Sciences
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now